Provided by Tiger Fintech (Singapore) Pte. Ltd.

Viking Therapeutics

32.01
-0.0600-0.19%
Post-market: 32.200.1900+0.59%19:59 EDT
Volume:3.39M
Turnover:109.42M
Market Cap:3.60B
PE:-27.76
High:33.16
Open:32.16
Low:31.28
Close:32.07
Loading ...

Viking Therapeutics price target lowered to $75 from $95 at Truist

TIPRANKS
·
28 Apr

Viking Therapeutics Inc : Truist Securities Cuts Target Price to $75 From $95

THOMSON REUTERS
·
28 Apr

Truist Securities Cuts Viking Therapeutics Price Target to $75 From $95, Maintains Buy Rating

MT Newswires Live
·
25 Apr

Viking Therapeutics: Promising Pipeline and Strategic Execution Drive Buy Rating

TIPRANKS
·
25 Apr

Viking Therapeutics (NasdaqCM:VKTX) Reports Increased Net Loss for Q1 2025

Simply Wall St.
·
25 Apr

Viking Therapeutics Is Maintained at Overweight by Morgan Stanley

Dow Jones
·
25 Apr

Novo Nordisk Plunges 17% in a Month: Buy, Sell or Hold the Stock?

Zacks
·
24 Apr

Viking Therapeutics price target lowered to $85 from $96 at B. Riley

TIPRANKS
·
24 Apr

B. Riley Adjusts Price Target on Viking Therapeutics to $85 From $96, Maintains Buy Rating

MT Newswires Live
·
24 Apr

Q1 2025 Viking Therapeutics Inc Earnings Call

Thomson Reuters StreetEvents
·
24 Apr

Viking Therapeutics Q1 Loss Wider Than Expected, Sales Nil, Stock Dips

Zacks
·
24 Apr

Viking Therapeutics: Strong Financials and Promising VK2735 Program Drive Buy Rating

TIPRANKS
·
24 Apr

Viking Therapeutics Inc (VKTX) Q1 2025 Earnings Call Highlights: Strategic Advances Amid Rising ...

GuruFocus.com
·
24 Apr

Viking Therapeutics, Inc. (VKTX): Among Takeover Rumors Hedge Funds Are Buying

Insider Monkey
·
24 Apr

Promising Developments and Financial Stability Underpin Buy Rating for Viking Therapeutics

TIPRANKS
·
24 Apr

Viking Therapeutics Stock Dips After Q1 EPS Miss: Details

Benzinga
·
24 Apr

Viking Therapeutics Q1 Loss Widens; Shares Drop After Hours

MT Newswires Live
·
24 Apr

Earnings Flash (VKTX) Viking Therapeutics Q1 Loss of $0.41 vs. FactSet Est Loss $0.33

MT Newswires Live
·
24 Apr

Viking Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
24 Apr

Viking Therapeutics reports Q1 EPS (41c), consensus (31c)

TIPRANKS
·
24 Apr